Safety Behavior Fading Versus Progressive Muscle Relaxation for Appearance Concerns (NCT07589621)
Safety Behavior Fading Versus Progressive Muscle Relaxation for Appearance Concerns: A Randomized Clinical Trial of Digital Interventions
🩺 Plain-English Summary (8th-Grade Level)
The current study aims to explore the efficacy of a text message based safety behavior fading intervention compared to a progressive muscle relaxation intervention for appearance concerns.
Who can join: Review the eligibility criteria below.
Location: Florida State University — Tallahassee, Florida
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
- Safety Behavior Fading for Appearance Concerns (BEHAVIORAL)
- Progressive Muscle Relaxation (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Florida State University — Tallahassee, Florida
📞 Contact the Study Coordinator
Phone: (863) 517-2584
Email: patel@psy.fsu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Body Dysmorphic Disorder
- Perceptual Abnormalities and Their Malleability in BDD — Toronto, Ontario
Explore by condition: All Body Dysmorphic Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.